{"id":890146,"date":"2025-09-29T09:48:20","date_gmt":"2025-09-29T13:48:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/"},"modified":"2025-09-29T09:48:20","modified_gmt":"2025-09-29T13:48:20","slug":"calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/","title":{"rendered":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN DIEGO, Sept.  29, 2025  (GLOBE NEWSWIRE) &#8212; Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (\u201cCalidi\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease,\u00a0today announced that its management will participate in the second annual Oncology Venture, Innovation, and Partnering Summit being held September 29-30, 2025, at the Westin Boston Seaport in Boston, MA.<\/p>\n<p>Eric Poma, Ph.D., Chief Executive Officer, will participate in a fireside chat with Dr. Aydin Huseynov, Managing Director and Senior Analyst at Ladenburg Thalmann, on the intersection of science and capital to develop and advance effective cancer treatments on September 30, 2025, at 10:10 a.m. E.T. Dr. Poma\u2019s presentation will highlight Calidi\u2019s RedTail platform, which is engineered to protect virus from immune clearance and induce tumor lysis and deliver potent therapeutic genetic medicines to metastatic sites through systemic administration.<\/p>\n<p>Dr. Poma will be available to participate in one-on-one meetings with participants registered to attend the conference.<\/p>\n<p>\n        <strong>About Calidi Biotherapeutics<\/strong>\n      <\/p>\n<p>Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company&#8217;s proprietary Redtail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent gene therapies to metastatic locations.<\/p>\n<p>The lead candidate from the Redtail platform, currently in IND-enabling studies, targets non-small cell lung cancer, ovarian cancer, and other tumor types with high unmet medical need. Additionally, Calidi is developing protected virotherapies, in clinical-stage, for intratumoral and localized administration, focusing on a subset of injectable cancer indications.<\/p>\n<p>Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VfN8aYje7gkftabHj7F9bJzMUy0d1F_n8QPSSkqULjEB3J8v9AsDTSsjiAqtrTnv6KIEwEAqDrhERE3LCp0r81ocBliSE1OfLsESSyAoLiztZXwi59NGKivv2sSlMCkj8ttU-ts8CVym3-FUx5i0UdA7XcB7Y_rFrHYw7VSU8QNtNAvmVdliYEij6cLASXbPv7ckxMOob33wOGtbBoRgLBdP_lqy8v9h0N9_Syizj_U4Jl2w8EeRP1gLNFI4qjkGFURJJggORgyX_JUfpAuaFhwy4OB0VygdUwCS5plvZt3Ba3pPjZhTY8YInKZC4RnCb3vj4-9lxkbcEvxnQI6_KryHhd9_fTcX-ZrT5H-L1GVUvSORcnyyqmFyM-Okvpw1HoBi4LMwOCeMkPk_sdIJyODqO7D9_cRv4TVw1icVAZ5b0mHNxWZEEi9cwEX3cL7EhIB9MY69XWKOktJjsXkgB3wTu46CHtL7SBGQJNklnWP05-4Ue5RGMewE6AA9mn-inQkRN6ELw-OWPcLYpF2mO0jifOuk6PqPBs2e8vVPL_k79UDvrtqwxPg86o1I_Bv-gOb68j5e1qaHFdAbK8Y1e79MXbw9WqX7g3OAUYz5ik-D-iThPuLXnDBXIKtp400AYoU7K_uh_cqS4hZSohyvAVpLSepPgOd2jrKhOHHKI8r3-wYcxYBEdEzvRBWx-fut3YSMhTf-tNFikTFpXUnueO0JO44OJRmYr8s5Zq5tFAuY4WF4AWAwbW8t_1_mnZHClmJ0JvzzTqLqi1df57lSyA==\" rel=\"nofollow\" target=\"_blank\"><strong>www.calidibio.com<\/strong><\/a>\u00a0or view Calidi\u2019s Corporate Presentation\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zpm3GOoNlMZb3o5NXBnPYb2KKDgZiEf1lLO1b1xPuQhvjD6t0SDBx7KduZSjoLDoaaaEkR5Cc6LDHz84bLeXzG6_xA6k0sO2p2SI-hzBK1mQfaPDfgPzP1oAjWbxYRUGGalDxJfXzXKnxCGVwDShOmrRY8DEJ8hqx_dZzjXVMyIkMS8rYM0BV96qTMvuU43kw-FRPw2VjEQp0wbvaG8goFr9D5gkyH_nhha_nT2fJL9QPQS-x8ogbaomWGBbasrtbW8x49-GVl4Gpu9nNC1FYRjmGaTUqKaSka3T232TOuDmvnWTatO0HS6-mP4XA8bf2WBbW5X8LiKtoVO3kAGi6bnZZs0yEFNdKEiEwrB_7tWycmnYQbUlLlxhslJFhPnX6B4hfgB5Sr974C35ZI10AA==\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release may contain forward-looking statements for purposes of the \u201csafe harbor\u201d provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as \u201canticipates,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintends,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cpotential,\u201d \u201cpredicts,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctowards,\u201d \u201cwould\u201d as well as similar terms, are forward-looking in nature, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements concerning key milestones, including certain pre-clinical data, planned clinical trials, and statements relating to the safety and efficacy of Calidi\u2019s therapeutic candidates in development. Any forward-looking statements contained in this discussion are based on Calidi\u2019s current expectations and beliefs concerning future developments and their potential effects and are subject to multiple risks and uncertainties that could cause actual results to differ materially and adversely from those set forth or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that Calidi is not able to raise sufficient capital to support its current and anticipated clinical trials, the risk that early results of clinical trials do not necessarily predict final results and that one or more of the clinical outcomes may materially change following more comprehensive review of the data, and as more patient data becomes available, the risk that Calidi may not receive FDA approval for some or all of its therapeutic candidates. Other risks and uncertainties are set forth in the section entitled \u201cRisk Factors\u201d and \u201cCautionary Note Regarding Forward-Looking Statements\u201d in the Company\u2019s annual report filed with the SEC on Form 10-K on March 31, 2025, as may be amended or supplemented by other reports we file with the SEC from time to time. We disclaim any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.<\/p>\n<p>\n        <strong>For Investors:<\/strong>\n      <\/p>\n<p>Dave Gentry, CEO<br \/>RedChip Companies, Inc.<br \/>1-407-644-4256<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sS752xB_GiBogjSZejI7IvFP06MvJi3Qu6zYaOE90HuJ9RvGUIzP_7f-HnLTlJ5PQ7hAvon0DIhgfAu_8bpjNaEOZbnawESVAJDxq3JZpu9lLDvpFEgjpkhf3EPNifzfPSTY6Iu8JEcYZaTp7W9dmCo1Pz0T-OIUgYg7Fh2TrJPp2nhbUPl_Hm9CQyPKxHpkO5d9kKT-m5Jg7pmXy_X9WSnA_Lx64sTaaoCblwsQ_4OYSmAiUD3kaz4DzVcG2o-r7SrDpvIVtx-2IbLhGfJ1d-L_yP9YBiOwMiA0rEY0GpKx5lPnpWF8Y-Ozc4x5crJdunJiGsQXizmCgGR9FeURAcPWaootSwG4oSgAIzhyYoZEIOKFU6QB0dA8IEyerfJRT6tFtDFPcYmgD96LOFDwoB-8IJ5s0MTmMFwLlzCJuTclbK8ts4zMMlanFV04rqiH1opIqUuizNVflLlNFLBKw7AavW9tk5t0HVOsQKUCdkM5SOlRsm0a8DRsE0725xTHiQGNWiCE58zugKugLiswKyE-dCAli991B4CMOj2uA--sdOP0Laf_HzFem-kljyoOS6IPBqk7FZPZQ9spbxeOuKHwGJ-dnXCUPe8sp8E6oba6Iv0JAWnezMKnw3e8qYMFuhDh5Xv4ECjUV8M9tFww3-sADK6fD1WZ1grn6YNlCUVsxPpM1Hxs_mexT3wnis_ko9BvuUdCzOspy6E5PRTuPQ==\" rel=\"nofollow\" target=\"_blank\">CLDI@redchip.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTI3YmVlY2EtZjQ1Ny00YmZhLWE0ZjYtNWE3MTIyMTc2MGQ3LTEyMDU0MDctMjAyNS0wOS0yOS1lbg==\/tiny\/Calidi-Biotherapeutics-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (\u201cCalidi\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease,\u00a0today announced that its management will participate in the second annual Oncology Venture, Innovation, and Partnering Summit being held September 29-30, 2025, at the Westin Boston Seaport in Boston, MA. Eric Poma, Ph.D., Chief Executive Officer, will participate in a fireside chat with Dr. Aydin Huseynov, Managing Director and Senior Analyst at Ladenburg Thalmann, on the intersection of science and capital to develop and advance effective cancer treatments on September 30, 2025, at 10:10 a.m. E.T. Dr. Poma\u2019s presentation will highlight &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-890146","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (\u201cCalidi\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease,\u00a0today announced that its management will participate in the second annual Oncology Venture, Innovation, and Partnering Summit being held September 29-30, 2025, at the Westin Boston Seaport in Boston, MA. Eric Poma, Ph.D., Chief Executive Officer, will participate in a fireside chat with Dr. Aydin Huseynov, Managing Director and Senior Analyst at Ladenburg Thalmann, on the intersection of science and capital to develop and advance effective cancer treatments on September 30, 2025, at 10:10 a.m. E.T. Dr. Poma\u2019s presentation will highlight &hellip; Continue reading &quot;Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T13:48:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston\",\"datePublished\":\"2025-09-29T13:48:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/\"},\"wordCount\":670,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/\",\"name\":\"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\",\"datePublished\":\"2025-09-29T13:48:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/","og_locale":"en_US","og_type":"article","og_title":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk","og_description":"SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (\u201cCalidi\u201d or the \u201cCompany\u201d), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease,\u00a0today announced that its management will participate in the second annual Oncology Venture, Innovation, and Partnering Summit being held September 29-30, 2025, at the Westin Boston Seaport in Boston, MA. Eric Poma, Ph.D., Chief Executive Officer, will participate in a fireside chat with Dr. Aydin Huseynov, Managing Director and Senior Analyst at Ladenburg Thalmann, on the intersection of science and capital to develop and advance effective cancer treatments on September 30, 2025, at 10:10 a.m. E.T. Dr. Poma\u2019s presentation will highlight &hellip; Continue reading \"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-29T13:48:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston","datePublished":"2025-09-29T13:48:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/"},"wordCount":670,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/","name":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=","datePublished":"2025-09-29T13:48:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjIwMCM3MTY3OTkzIzIxOTM4NTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calidi-biotherapeutics-to-present-at-the-second-annual-oncology-venture-innovation-and-partnering-summit-in-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=890146"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890146\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=890146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=890146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=890146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}